Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: MasterLink Securities Corporation
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

G&E Herbal Biotechnology Co Ltd Receives Drug Permit License


Friday, 6 Sep 2013 03:10am EDT 

G&E Herbal Biotechnology Co Ltd announced that it has received a drug permit license for a capsule product for liver disease from Food and Drug Administration, Ministry of Health and Welfare. The classification of the permit is over the counter (OTC) drug permit. 

Company Quote

143.5
-0.5 -0.35%
1:30am EDT